Concord Wealth Partners - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 336 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
Concord Wealth Partners ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$1,360
-54.7%
36
-56.1%
0.00%
-100.0%
Q2 2022$3,000
-50.0%
82
-46.4%
0.00%
-50.0%
Q1 2022$6,000
-57.1%
153
-66.2%
0.00%
-33.3%
Q4 2021$14,000
+250.0%
453
+287.2%
0.00%
+50.0%
Q3 2021$4,000
-76.5%
117
-71.9%
0.00%
-60.0%
Q2 2021$17,000
-10.5%
4170.0%0.01%
-16.7%
Q1 2021$19,000
+11.8%
417
+39.0%
0.01%
-53.8%
Q4 2020$17,0003000.01%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,541,046$126,5576.89%
M28 Capital Management LP 126,300$4,513,9625.10%
Bellevue Group AG 9,511,900$339,955,3064.93%
Deep Track Capital, LP 2,834,069$101,289,6264.16%
BVF INC/IL 2,560,761$91,521,5983.35%
Sicart Associates LLC 210,698$7,530,3472.93%
Privium Fund Management B.V. 182,773$6,532,3072.19%
Camber Capital Management LP 1,925,000$68,8002.12%
Orbimed Advisors 2,124,500$75,929,6301.49%
SECTOR GAMMA AS 146,441$5,233,8011.27%
View complete list of IONIS PHARMACEUTICALS INC shareholders